BMJ  2007;334:383 (24 February), doi:10.1136/bmj.39133.543438.DB

News

NHS pays £500m too much for prescription drugs

London

The first 150 words of the full text of this article appear below.

The UK health services are overpaying by about £500m (740m; $980m) a year for prescription drugs, says a government report published this week. This is because of the current system for pricing drugs in the United Kingdom, it says, and it calls for the pricing scheme to be changed to reflect the benefit of drugs to patients.

The report, from the Office of Fair Trading, a body that protects consumers' interests in the UK, found that many alternative products were available in the areas of greatest NHS expenditure, including drugs for raised cholesterol concentrations and high blood pressure.

Several drugs currently prescribed in large volumes were up to 10 times more expensive than alternatives that the researchers considered delivered very similar benefits to patients. They argue that hundreds of millions of pounds are spent on the more expensive products each year, restricting funds available for other drugs.

On the . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

NICE is accused of "jockeying for position" in new drug pricing scheme

Michael Day
BMJ 2008 337: a1422. [Extract] [Full Text]

Government and industry reach new pricing deal to cut NHS drugs bill

Andrew Jack
BMJ 2008 336: 1455. [Extract] [Full Text] [PDF]

Government pushes ahead with plan for cheaper drugs deal for NHS

Nicholas Timmins
BMJ 2007 335: 273. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Hardly a new finding

Andrew P Moltu, et al.
bmj.com, 24 Feb 2007 [Full text]

Rather old news really

John D K Pope
bmj.com, 28 Feb 2007 [Full text]

Fair prices for new drugs and insulin discontinuations

Alan Meakin, et al.
bmj.com, 20 Apr 2007 [Full text]

Online poll

Find out more >>